BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

EHMT2

MOLECULAR TARGET

euchromatic histone lysine methyltransferase 2

UniProt: Q96KQ7NCBI Gene: 1091918 compounds

EHMT2 (euchromatic histone lysine methyltransferase 2) is targeted by 18 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting EHMT2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1ebselen4.74113
2sinefungin3.7441
3naphthoquinone3.5835
4raltitrexed3.5835
5ditiocarb sodium3.5333
6chaetocin2.9418
7thiram2.4811
8Disulfiram1.956
9chetomin1.956
10s adenosylhomocysteine1.795
11benzene selenoic acid1.795
12Cyproheptadine1.393
13Gliotoxin1.102
14Glutathione0.691
15Anthraquinones Compounds based on ANTHRACENES which contain two KETONES in0.691
16Dimethyl Sulfoxide0.691
17ninhydrin0.691
18bdb chembl21724260.691

About EHMT2 as a Drug Target

EHMT2 (euchromatic histone lysine methyltransferase 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 18 compounds with documented EHMT2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

EHMT2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.